In this chapter, we present a short overview of those COVID-associated changes related to PDEs and provide the data about ongoing clinical studies where the PDE inhibitors have been administered to patients with COVID-19-induced ARDS. The gene discussed is ALDH7A1; the disease is COVID-19.